Fig. 6.
![Fig. 6. Whole blood coagulation and Integrilin. / Comparison of whole blood coagulation in the absence (▪) and presence (●) of 5 μM Integrilin. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times for the control experiment, arrow “b” for the Integrilin experiment.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/97/8/10.1182_blood.v97.8.2314/5/h80810935006.jpeg?Expires=1735834952&Signature=jrGnfGwfiWKJbt84MC98WUKUUzQve4j2xcx1HPy1zDuswgc3Ywh0mPR7LV5chEx4ExWLIpOcmmCfOM2IiROt6LfwWhXKtBjkqDRNt7OODT-mc2wVzyEec7p6t437yBl1n6N5~pw3Q4sbJWkiCPVNwhdJTWf54155b6~jUvPs5oydkLVcFDq4Mc6H6-b38FiFHuQdBLvVUOr03peozzL-LmntnzI5CWf7zvT-9MLdBuEcD7gmQZCVlcmB0hRHYdvQvIm9i5D-oDYggiKT-upNzrHjt-cpG07YVe8FJ2boJG-0E7dZxIuP458YB9gzRjf54jGlHM3iRQoU7bbcXsHv1g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Whole blood coagulation and Integrilin.
Comparison of whole blood coagulation in the absence (▪) and presence (●) of 5 μM Integrilin. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times for the control experiment, arrow “b” for the Integrilin experiment.
